๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cellular mechanisms underlying the excitatory actions of ATP in vascular smooth muscle

โœ Scribed by Charles Kennedy


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
434 KB
Volume
28
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

โœฆ Synopsis


It i s now clear that noradrenaline (NA) is not the sole excitatory cotransmitter in perivascular sympathetic nerves, as both adenosine 5'-triphosphate (ATP) and neuropeptide Y (NPY) are co-stored with NA in synaptic vesicles and co-released during nerve stimulation. The relative contribution of these compounds to neurogenic contractions i s dependent upon the species, vessel and parameters of stimulation studied. Stimulation of the perivascular nerves evokes excitatory junction potentials (ejps) which, in most vessels are resistant to a-adrenoceptor antagonists. The ejps are mediated by ATP, as they are selectively abolished by desensitisation of the P,,-purinoceptor by (.r,P-MeATP or by the selective P,-antagonist, suramin. in many vessels a component of the neurogenic contraction also shows resistance to a-adrenoceptor blockade but can be inhibited by a,P-MeATP or suramin. In the limited number of vessels studied t o date, ATP has been found to act via several ionic mechanisms, including an increase in a non-specific, cationic current and an increase in a chloride current. These currents appear to have a variable distribution and are not all present in all vessels. This may allow vessels a differential response to ATP depending on their function. However, the distribution, role and relative importance of these effects i s not yet known. As well as its direct contractile effects, ATP also interacts in a synergistic manner with NA and NPY. The mechanisms which underlie these effects are unclear but may involve an increase in the current through L-type calcium channels. Clearly, vascular neurotransmission is not the simple process previously envisaged.


๐Ÿ“œ SIMILAR VOLUMES


Molecular mechanisms of the antiprolifer
โœ Heng Lin; Ja-Ling Lee; Hsin-Han Hou; Chih-Peng Chung; Sung-Po Hsu; Shu-Hui Juan ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 304 KB

## Abstract Prostacyclin (PGI~2~) has been shown to inhibit proliferation in vascular smooth muscle cells. To clarify the underlying molecular mechanism, we investigated the vasoprotection of beraprost (a PGI~2~ agonist) both in vivo and in vitro. Beraprost eliminated increases in proliferation of

Phosphatidylinositol- and phosphatidylch
โœ Antonella Zannetti; Paolo Luly; Roberto Musanti; Patrizia M. Baldini ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB ๐Ÿ‘ 2 views

We have investigated the involvement of specific phospholipase systems and their possible mutual relationship with the mechanism by which atrial natriuretic factor (ANF) increases phosphatidate (PA) and diacylglycerol (DAG) in rat aortic smooth muscle cells (RASMC), one of the major targets of this